New treatments are needed for alcohol addiction. Are drugs like Ozempic the answer?
There's growing evidence to suggest that GLP-1 drugs, which include semaglutide, may be useful for treating alcohol use disorder.
Medincell: Completion of the Pivotal Phase 3 Trial for Olanzapine LAI in Schizophrenia Conducted by Teva Pharmaceuticals
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DozQrLpG.js ...
Completion of the Pivotal Phase 3 Trial for Olanzapine LAI in Schizophrenia Conducted by Teva Pharmaceuticals
Richard Malamut, Chief Medical Officer at Medincell comments: "Our partner is advancing the clinical development of the olanzapine LAI with plans for regulatory submission in the US. This structured ...